KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Novartis Ag (NVS) FCF Margin (2016 - 2024)

Novartis Ag's FCF Margin history spans 13 years, with the latest figure at 41.04% for Q2 2024.

  • On a quarterly basis, FCF Margin rose 2674.0% to 41.04% in Q2 2024 year-over-year; TTM through Jun 2024 was 35.56%, a 169.0% decrease, with the full-year FY2025 number at 32.27%, down 3.0% from a year prior.
  • FCF Margin hit 41.04% in Q2 2024 for Novartis Ag, up from 31.21% in the prior quarter.
  • Over the last five years, FCF Margin for NVS hit a ceiling of 2896.69% in Q4 2020 and a floor of 14.3% in Q2 2023.
  • Historically, FCF Margin has averaged 375.23% across 5 years, with a median of 69.7% in 2021.
  • Biggest five-year swings in FCF Margin: tumbled -288070bps in 2021 and later skyrocketed 223204bps in 2022.
  • Tracing NVS's FCF Margin over 5 years: stood at 2896.69% in 2020, then crashed by -99bps to 15.99% in 2021, then surged by 13957bps to 2248.03% in 2022, then plummeted by -99bps to 31.21% in 2023, then soared by 32bps to 41.04% in 2024.
  • Business Quant data shows FCF Margin for NVS at 41.04% in Q2 2024, 31.21% in Q4 2023, and 14.3% in Q2 2023.